Medindia

X

BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule

Tuesday, July 27, 2010 Corporate News J E 4
Advertisement


WALL, N.J., July 27 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today announced plans to release second quarter 2010 financial results on Wednesday, July 28, 2010 after the market closes. In conjunction with the release, BIO-key has scheduled a conference call, which will be broadcast live over the Internet on Thursday, July 29, 2010 at 10:00 a.m. Eastern Time.

(Logo: http://photos.prnewswire.com/prnh/20050509/BIOKEYLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh//20050509/BIOKEYLOGO)

A streaming audio replay of the webcast will be available shortly after the call on www.bio-key.com for a period of thirty days.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

BIO-key Safe Harbor Statement

Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

BIO-key International, Inc. Second Quarter 2010 Conference What: Call When: Thursday, July 29, 2010 - 10:00 a.m. Eastern Time Live via phone by dialing 800-860-2442 and asking for the BIO-key call at least 10 minutes prior to the start time. Or live over the Internet by logging on to the web address Where: below. Where: http://www.bio-key.com

SOURCE BIO-key International, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Arena Pharmaceuticals to Host Business and Financi...
S
BioElectronics and YesDTC Holdings Receive Japanes...